Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR
Condition(s) studied
Investigational drug(s) / intervention(s)
Comprehensive physiologic evaluation: Comprehensive physiologic evaluation using pressure-temperature sensor wire to measure fractional flow reserve, coronary flow reserve, index of microcirculatory resistance
Intravascular imaging devices: Intravascular ultrasound or optical coherence tomography
Study summary
1. To compare the risk of atherosclerotic lesion progression and subsequent patient-oriented composite outcomes (all-cause mortality, any MI, or any Ischemia-driven repeat revascularization) between deferred lesions with or without over microvascular disease, defined as physiological classification
2. To explore independent predictors of atherosclerotic lesion progression in deferred lesions based on fractional flow reserve-guided strategy and treated by contemporary medical treatment
Eligibility
Primary outcome measure(s)
- patient-oriented composite outcome — 24 months
a composite of all-cause death, MI, any repeat revascularization
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Keimyung University Dongsan Medical Center | Daegu | South Korea | |
| Inje University Ilsan Paik Hospital | Goyang-si | South Korea | |
| Samsung Medical Center | Seoul | South Korea | |
| Seoul National University Hospital | Seoul | South Korea |
More Samsung Medical Center trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03030495 on ClinicalTrials.gov ↗ ← All trials in South Korea